The Gut Microbiome and Anxiety: Difference between revisions

From MicrobeWiki, the student-edited microbiology resource
No edit summary
No edit summary
Line 13: Line 13:


==Hormones, Neurotransmitters, and Peptides==
==Hormones, Neurotransmitters, and Peptides==
[[Image: ElevatedPlusMazeKnockoutData.jpeg |thumb | 300px | right | Results of the elevated plus maze in Y2 and Y4 receptor knockout mice, compared to control mice. Painsipp et al. 2008. <ref name=ss/> [https://www-ncbi-nlm-nih-gov.libproxy.kenyon.edu/pmc/articles/PMC4359911/figure/F3/?report=objectonly] ]]
To understand how the gut microbiome plays a role in anxiety, we must understand what hormones, neurotransmitters, and peptides are involved in mediating this relationship. By studying the HPA axis, we have established that the hormones in the HPA axis—corticotropin releasing hormone, adrenocorticotropic hormone, and cortisol—are important. While the HPA axis is involved in anxiety, we must also examine other neurotransmitters and peptides that may be more directly involved in anxiety. <br>
To understand how the gut microbiome plays a role in anxiety, we must understand what hormones, neurotransmitters, and peptides are involved in mediating this relationship. By studying the HPA axis, we have established that the hormones in the HPA axis—corticotropin releasing hormone, adrenocorticotropic hormone, and cortisol—are important. While the HPA axis is involved in anxiety, we must also examine other neurotransmitters and peptides that may be more directly involved in anxiety. <br>
Neurotransmitters are chemicals that act on neurons, but they are not limited to the central nervous system. In fact, many neurotransmitters are found in the gut, made by the gut microbiome. <ref name=pp>[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147657/=PDF Sun, L., Li, J., Nie, Z. “Gut hormones in microbiota-gut-brain cross-talk” 2020. Chinese Medical Journal  133:7, 826-833.]</ref> Some examples of this include <i>Candida</i> or <i>Echerichia</i> synthesizing and releasing serotonin, or dopamine synthesized by <i>Bacillus</i>. <ref name=pp/> These are common gut microbes. While these neurotransmitters cannot always cross the blood-brain barrier, they can still act on parts of the peripheral nervous system and the vagus nerve. <ref name=pp/> Somewhat counterintuitively, peptides may be how the gut microbiome is involved in anxiety. The volume of gut peptides and neurotransmitters that the gut microbiome is responsible for in some part (synthesizing, stimulating release, altering, or activating) makes the gut one of the largest centers of endocrinology, immunology, and neuroscience. There are many types of peptides influenced by microbes, but neuropeptide Y (NPY), peptide YY (PYY), and pancreatic polypeptide (PP), are three peptides most commonly implicated in anxiety. <ref name=qq>[https://www-ncbi-nlm-nih-gov.libproxy.kenyon.edu/pmc/articles/PMC5794698/=PDF Lach, G., Schellekens, H., Dinan, T.G., Cryan, J.F. “Anxiety, depression, and the microbiome: a role for gut peptides.” 2018. Neurotherapeutics. 15:1, 36-59.] </ref>  
Neurotransmitters are chemicals that act on neurons, but they are not limited to the central nervous system. In fact, many neurotransmitters are found in the gut, made by the gut microbiome. <ref name=pp>[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147657/=PDF Sun, L., Li, J., Nie, Z. “Gut hormones in microbiota-gut-brain cross-talk” 2020. Chinese Medical Journal  133:7, 826-833.]</ref> Some examples of this include <i>Candida</i> or <i>Echerichia</i> synthesizing and releasing serotonin, or dopamine synthesized by <i>Bacillus</i>. <ref name=pp/> These are common gut microbes. While these neurotransmitters cannot always cross the blood-brain barrier, they can still act on parts of the peripheral nervous system and the vagus nerve. <ref name=pp/> Somewhat counterintuitively, peptides may be how the gut microbiome is involved in anxiety. The volume of gut peptides and neurotransmitters that the gut microbiome is responsible for in some part (synthesizing, stimulating release, altering, or activating) makes the gut one of the largest centers of endocrinology, immunology, and neuroscience. There are many types of peptides influenced by microbes, but neuropeptide Y (NPY), peptide YY (PYY), and pancreatic polypeptide (PP), are three peptides most commonly implicated in anxiety. <ref name=qq>[https://www-ncbi-nlm-nih-gov.libproxy.kenyon.edu/pmc/articles/PMC5794698/=PDF Lach, G., Schellekens, H., Dinan, T.G., Cryan, J.F. “Anxiety, depression, and the microbiome: a role for gut peptides.” 2018. Neurotherapeutics. 15:1, 36-59.] </ref>  
<br>
<br>
One study that showed the effects of NPY on anxiety was conducted by Painsipp et al. in 2008. <ref name=ss>[https://www-ncbi-nlm-nih-gov.libproxy.kenyon.edu/pmc/articles/PMC4359911/=PDF Painsipp, E., Wultsch, T., Edelsbrunner, M., Tasan, R., Singewald, N., Herzog, H., Holzer, P. “Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice” 2008. Genes Brain Behav. 7:5, 532-542.] </ref> There are six classes of NPY receptors. This study used mice that either lacked the NPY2 receptor (Y2-/-) or NPY4 receptor (Y4-/-). Using a variety of anxiety-linked behavioral tests, they were able to compare these groups with a control group to elucidate the effects of NPY via these two receptors on anxiety. They found that the Y4-/- mice and Y2-/- mice had reduced anxiety-like behavior for behavioral tests such as the elevated plus maze, but only Y4-/- exhibited reduced anxiety-like behavior in other tests. <ref name=ss/> However, the control group never exhibited less anxiety-like behavior than either knockout. In an elevated plus maze, there is a plus-shaped maze elevated off the ground with two arms open and two arms enclosed. More time on the open arms as well as more exploratory behavior indicates a lower level of anxiety; an anxious mouse will spend more time in closed arms, taking cover. Reduced anxiety can be inferred through every measure of the elevated plus maze for the Y4 and Y2 knockouts. This helps us understand how the NPY2 and NPY4 receptors are important in anxiety. The gut microbiome and NPY both influence each other; this study more directly tying the gut microbiome to molecules that are important in anxiety. <ref name=rr>[https://www-ncbi-nlm-nih-gov.libproxy.kenyon.edu/pmc/articles/PMC4359909/=PDF Holzer, P., Farzi, A. “Neuropeptides and the Microbiota-Gut-Brain Axis” 2014. Adv Exp Med Biol. 817:195-219.]</ref>  <br>
One study that showed the effects of NPY on anxiety was conducted by Painsipp et al. in 2008. <ref name=ss>[https://www-ncbi-nlm-nih-gov.libproxy.kenyon.edu/pmc/articles/PMC4359911/=PDF Painsipp, E., Wultsch, T., Edelsbrunner, M., Tasan, R., Singewald, N., Herzog, H., Holzer, P. “Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice” 2008. Genes Brain Behav. 7:5, 532-542.] </ref> There are six classes of NPY receptors. This study used mice that either lacked the NPY2 receptor (Y2-/-) or NPY4 receptor (Y4-/-). Using a variety of anxiety-linked behavioral tests, they were able to compare these groups with a control group to elucidate the effects of NPY via these two receptors on anxiety. They found that the Y4-/- mice and Y2-/- mice had reduced anxiety-like behavior for behavioral tests such as the elevated plus maze, but only Y4-/- exhibited reduced anxiety-like behavior in other tests. <ref name=ss/> However, the control group never exhibited less anxiety-like behavior than either knockout. In an elevated plus maze, there is a plus-shaped maze elevated off the ground with two arms open and two arms enclosed. More time on the open arms as well as more exploratory behavior indicates a lower level of anxiety; an anxious mouse will spend more time in closed arms, taking cover. Reduced anxiety can be inferred through every measure of the elevated plus maze for the Y4 and Y2 knockouts. This helps us understand how the NPY2 and NPY4 receptors are important in anxiety. The gut microbiome and NPY both influence each other; this study more directly tying the gut microbiome to molecules that are important in anxiety. <ref name=rr>[https://www-ncbi-nlm-nih-gov.libproxy.kenyon.edu/pmc/articles/PMC4359909/=PDF Holzer, P., Farzi, A. “Neuropeptides and the Microbiota-Gut-Brain Axis” 2014. Adv Exp Med Biol. 817:195-219.]</ref>  <br>
[[Image: ElevatedPlusMazeKnockoutData.jpeg |thumb | 400px | right | Results of the elevated plus maze in Y2 and Y4 receptor knockout mice, compared to control mice. Painsipp et al. 2008. <ref name=ss/> [https://www-ncbi-nlm-nih-gov.libproxy.kenyon.edu/pmc/articles/PMC4359911/figure/F3/?report=objectonly] ]]
 
==Specific Bacteria==
==Specific Bacteria==
==Clinical Implications==
==Clinical Implications==
==References==
==References==
<references />
<references />

Revision as of 19:43, 3 April 2021

This is a curated page. Report corrections to Microbewiki.

Introduction to the Gut-Brain Axis


By Laura Grosh

When people think of organs, they would likely not list the gut microbiome. Increasing research, however, is starting to change this assumption. The gut microbiome is a dynamic collection of microbes that live in our intestinal tract, and we are beginning to see that this microbial community is as integral to our health as the organs that may initially come to mind such as the heart or lungs. The gut microbiome is huge; recent estimates state that in a 70 kg person, 0.2 kg are bacteria, many of which reside in the gut. [1] One way that the gut microbiome is vital to us in through their connection to our nervous system. Microbes are directly responsible for making neurotransmitters and neuropeptides, integrating them into the nervous system—but the connection between these seemingly separated systems extends beyond this. The vagus nerve connects the brain and the gut, a direct representation of the gut-brain axis. [2] Autonomic, immune, and endocrine responses further complicate and interact with this connection between the gut microbiome and our nervous system. Research has addressed this connection by performing metagenomic analyses on the gut microbiome, studying model organism lacking commensal bacteria, altering the gut microbiome through probiotics or antibiotics, activating or deactivating the vagus nerve, among many other molecular and genomic manipulations [3] Studying this connection, as complicated as it is, is beginning to uncover the implications of the gut microbiome on mental health. The gut microbiome is increasingly believed to facilitate relationships between stress and anxiety, both in direct and indirect ways.[4] This has direct implications on public health and the field of mental health, and could even increase treatment options for anxiety in the future.

Stress and the HPA axis

An overview of the HPA axis. Wikimedia Commons.[1]

One way that the gut microbiome may influence anxiety is through the relationship between the gut microbiome and the HPA axis, stress and inflammation. The HPA axis is a system that modulates stress responses. When a physical or psychological stressor appears, the hypothalamus sends signals to the pituitary gland, which releases adrenocorticotropic hormone. This hormone acts on the adrenal glands to release cortisol, which is the bodies main stress hormone. In an ideal world, cortisone provides negative feedback for both the hypothalamus and pituitary gland. [5] Of course, in the less than perfect body’s we inhabit and in an increasingly stressful world, this can go sometimes go wrong. Our stress response is not the same thing as clinical anxiety, but there are many correlations that make the HPA axis an interesting thing to study when asking questions about anxiety. Dysregulation of the stress response and HPA axis, behaviorally observed as chronic stress, is highly co-morbid with anxiety. [6] To further support the connection between HPA axis and anxiety, patients with anxiety disorders show an increased cortisol response, suggesting an increase in HPA axis activity. [7] Understanding how the gut microbiome influences the HPA axis is the first step in understanding how the gut microbiome affects anxiety.
The influence of the microbiome on stress and the HPA axis may start from birth. Observed in mice, maternal stress during pregnancy and offspring stress in early life both lead to dysbiosis (an abnormal gut microbiome) and altered development of the HPA axis. [8] [9] This is likely because both the gut microbiome and the HPA axis are not yet developed at birth. These findings lead us to believe that the gut microbiome, both at birth and in early development, is connected to the development of the HPA axis. [10] Germ free (GF) mice are a common model organism for studying the relationship between gut microbiota and behavior. GF mice are raised without exposure to microorganisms, giving us insight into what behaviors and processes are impacted without a microbiome. Using GF mice has proven to be extremely useful when studying the gut-brain axis. [11]
Multiple studies have used GF mice to examine HPA development and function. Fascinatingly, not all studies using GF mice yield the same effects on HPA function. One such study, done by Huo et al. in 2017, used a population of GF mice and mice free from specific pathogens (specific pathogen free mice, or SPF mice). After chronic restraint to induce stress, the researchers measured exploratory time, a behavior associated with stress level, as well as level of hormones released by the HPA axis. In the stressed subject groups, they found that GF mice had significantly higher stress hormone levels compared to SPF mice. However, the GF mice exhibited more exploratory behavior than the SPF mice. [12] Other studies, however, have found an increase in anxiety-associated behavior in GF rats compared to SPF rats, and similar dysregulation of HPA axis-related hormones. [13] Even though there is contradictory evidence whether GF animals experience more or less anxiety, it is clear that the microbiome does play a role in anxiety-like behavior by modulating the HPA axis.

Hormones, Neurotransmitters, and Peptides

Results of the elevated plus maze in Y2 and Y4 receptor knockout mice, compared to control mice. Painsipp et al. 2008. [14] [2]

To understand how the gut microbiome plays a role in anxiety, we must understand what hormones, neurotransmitters, and peptides are involved in mediating this relationship. By studying the HPA axis, we have established that the hormones in the HPA axis—corticotropin releasing hormone, adrenocorticotropic hormone, and cortisol—are important. While the HPA axis is involved in anxiety, we must also examine other neurotransmitters and peptides that may be more directly involved in anxiety.
Neurotransmitters are chemicals that act on neurons, but they are not limited to the central nervous system. In fact, many neurotransmitters are found in the gut, made by the gut microbiome. [15] Some examples of this include Candida or Echerichia synthesizing and releasing serotonin, or dopamine synthesized by Bacillus. [15] These are common gut microbes. While these neurotransmitters cannot always cross the blood-brain barrier, they can still act on parts of the peripheral nervous system and the vagus nerve. [15] Somewhat counterintuitively, peptides may be how the gut microbiome is involved in anxiety. The volume of gut peptides and neurotransmitters that the gut microbiome is responsible for in some part (synthesizing, stimulating release, altering, or activating) makes the gut one of the largest centers of endocrinology, immunology, and neuroscience. There are many types of peptides influenced by microbes, but neuropeptide Y (NPY), peptide YY (PYY), and pancreatic polypeptide (PP), are three peptides most commonly implicated in anxiety. [16]
One study that showed the effects of NPY on anxiety was conducted by Painsipp et al. in 2008. [14] There are six classes of NPY receptors. This study used mice that either lacked the NPY2 receptor (Y2-/-) or NPY4 receptor (Y4-/-). Using a variety of anxiety-linked behavioral tests, they were able to compare these groups with a control group to elucidate the effects of NPY via these two receptors on anxiety. They found that the Y4-/- mice and Y2-/- mice had reduced anxiety-like behavior for behavioral tests such as the elevated plus maze, but only Y4-/- exhibited reduced anxiety-like behavior in other tests. [14] However, the control group never exhibited less anxiety-like behavior than either knockout. In an elevated plus maze, there is a plus-shaped maze elevated off the ground with two arms open and two arms enclosed. More time on the open arms as well as more exploratory behavior indicates a lower level of anxiety; an anxious mouse will spend more time in closed arms, taking cover. Reduced anxiety can be inferred through every measure of the elevated plus maze for the Y4 and Y2 knockouts. This helps us understand how the NPY2 and NPY4 receptors are important in anxiety. The gut microbiome and NPY both influence each other; this study more directly tying the gut microbiome to molecules that are important in anxiety. [17]

Specific Bacteria

Clinical Implications

References

  1. Sender, R., Fuchs, S., Milo, R. “Revised “Estimates for the Number of Human and Bacteria Cells in the Body” 2016. PLoS Biology 14:8, 1002533.
  2. Browning, K., Verheijden, S., and Boeckxstaens, G."The Vagus Nerve in Appetite Regulation, Mood, and Intestinal Inflammation" 2017. Gastroenterology 152:4, 730-744.
  3. Foster, J. and McVey Neufeld, K.” Gut-brain axis: how the microbiome influences anxiety and depression.” 2013. Trends in Neurosciences: 36:5, 305-312.
  4. Peirce, J. and Alvina, K. "The role of inflammation and the gut microbiome in depression and anxiety" 2019. J. Neurosci. Res. 97:10, 1223-1241.
  5. Godoy, L.D., Rossignoli, M.T., Delfino-Pereira, P., Garcia-Cairasco, N., de Lima Umeoka, E.H. “A comprehensive overview on stress neurobiology: Basic concepts and clinical implications” 2018. Front Behav Neurosci. 12:127.
  6. Fernandes, V., Osorio, F.L. “Are there associations between early emotional trauma and anxiety disorders? Evidence fro ma systematic literature review and meta-analysis.” 2015. Eur Psychiatry. 30:6, 756-765.
  7. Zorn, J.V., Schur, R.R., Boks, M.P., Kahn, R.S., Joels, M., Vinkers, C.H. “Cortisol stress reactivity across psychiatric disorders: A systematic review and meta-analysis.” 2016. Psyneuen. 77:25-36.
  8. Gur, T.L. Palkar, A.V. Rajesekera, T., Allen, J., Niraula, A., Godbout, J., Bailey, M.T. “Prenatal stress disrupts social behavior, cortical neurobiology and commensal microbes in adult male offspring.” 2019. Behav Brain Research. 359:886-894.
  9. Fankiensztajn, L.M., Elliott, E., Koren, O. “The microbiota and the HPA axis, implications for anxiety and stress disorders.” 2020. Current Opinion in Neurobiology. 62:76-82.
  10. de Weerth, C. “Do bacteria shape our development? Crosstalk between intestinal microbiota and HPA axis.” 2017. Neuro and Behav Reviews. 83:458-471.
  11. Luczyniski, P, Neufeld, K.M., Oriach, C.S., Slarke, G., Dinan, T.G., Cryan, J.F. “Growing up in a bubble: Using germ-free animals to assess the influence of the gut microbiota on brain and behavior” 2016. Int J Neuropsychopharmacol. 19:8.
  12. Huo, R., Zeng, B., Zeng, L., Cheng, K., Li, B., Luo, Y., Wang, H., Zhou, C., Fang, L., Li, W., Niu, R., Wei, H., Xie, P. “Microbiota modulate anxiety-like behavior and endocrine abnormalities in hypothalamic-pituitary-adrenal axis.” 2017. Front. Cell. Infect. Microbio.
  13. Crumeyrolle-Arias, M., Jaglin, M., Bruneau, A., Vancassel, S., Dauge, V., Naudon, L., Rabot, S. “Absence of the gut microbiota enhances anxiety-like behavior and neuroendocrine response to acute stress in rats.” 2014. Psychoneuroendocrinology. 42:207-217.
  14. 14.0 14.1 14.2 Painsipp, E., Wultsch, T., Edelsbrunner, M., Tasan, R., Singewald, N., Herzog, H., Holzer, P. “Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice” 2008. Genes Brain Behav. 7:5, 532-542.
  15. 15.0 15.1 15.2 Sun, L., Li, J., Nie, Z. “Gut hormones in microbiota-gut-brain cross-talk” 2020. Chinese Medical Journal 133:7, 826-833.
  16. Lach, G., Schellekens, H., Dinan, T.G., Cryan, J.F. “Anxiety, depression, and the microbiome: a role for gut peptides.” 2018. Neurotherapeutics. 15:1, 36-59.
  17. Holzer, P., Farzi, A. “Neuropeptides and the Microbiota-Gut-Brain Axis” 2014. Adv Exp Med Biol. 817:195-219.